Disease characteristics of HLA-B27 positive and negative finnish patients with juvenile idiopathic arthritis - results of the 18-year cohort follow-up study

Abstract Background The aim of this long-term follow-up study was to compare the disease characteristics of HLA-B27 positive and negative patients with juvenile idiopathic arthritis (JIA). Methods The study is a cohort study with consecutive cases of newly diagnosed Finnish patients with JIA accordi...

Full description

Bibliographic Details
Main Authors: Suvi Oili Orvokki Peltoniemi, Mia Glerup, Pekka Lahdenne, Kari K Eklund, Kristiina Aalto
Format: Article
Language:English
Published: BMC 2023-09-01
Series:Pediatric Rheumatology Online Journal
Subjects:
Online Access:https://doi.org/10.1186/s12969-023-00878-9
_version_ 1827724046217773056
author Suvi Oili Orvokki Peltoniemi
Mia Glerup
Pekka Lahdenne
Kari K Eklund
Kristiina Aalto
author_facet Suvi Oili Orvokki Peltoniemi
Mia Glerup
Pekka Lahdenne
Kari K Eklund
Kristiina Aalto
author_sort Suvi Oili Orvokki Peltoniemi
collection DOAJ
description Abstract Background The aim of this long-term follow-up study was to compare the disease characteristics of HLA-B27 positive and negative patients with juvenile idiopathic arthritis (JIA). Methods The study is a cohort study with consecutive cases of newly diagnosed Finnish patients with JIA according to the International League of Associations for Rheumatology (ILAR) criteria [1]. Patients were enrolled between 1997 and 2000 from a defined area of Southern Finland. Clinical data including disease activity and serology were registered during a mean period of 17.5 years. Results 159 patients completed the 18-year follow-up study. HLA-B27 was available for 151 patients, of which 25% were HLA-B27 positive. Chronic uveitis was diagnosed in 30% of HLA-B27 positive and 29% of HLA-B27 negative patients. HLA-B27 positive patients had a lower prevalence of temporomandibular (TMJ) involvement than the antigen negative ones, 19% versus 28%. None of the HLA-B27 positive patients had cervical spine affected compared to 11% of antigen negative patients (p = 0.022). Of the HLA-B27 positive patients, 54% had had biological medication at some point during follow-up versus 25% in the negative group (p = 0.003). At last follow-up, 32% of antigen positive patients were not in remission compared to 18% of the antigen negative (p = 0.017). Conclusions The use of biological medication was more common in HLA-B27 positive patients with JIA. At the 18-year follow-up, more antigen positive patients had active disease compared HLA-B27 negative patients. This real-world follow-up study indicates that the prospects for worse outcome with HLA-B27 positivity in long-term should be taken into consideration.
first_indexed 2024-03-10T22:09:20Z
format Article
id doaj.art-5e73a098a240424c95fb77a7c04c3352
institution Directory Open Access Journal
issn 1546-0096
language English
last_indexed 2024-03-10T22:09:20Z
publishDate 2023-09-01
publisher BMC
record_format Article
series Pediatric Rheumatology Online Journal
spelling doaj.art-5e73a098a240424c95fb77a7c04c33522023-11-19T12:39:57ZengBMCPediatric Rheumatology Online Journal1546-00962023-09-012111710.1186/s12969-023-00878-9Disease characteristics of HLA-B27 positive and negative finnish patients with juvenile idiopathic arthritis - results of the 18-year cohort follow-up studySuvi Oili Orvokki Peltoniemi0Mia Glerup1Pekka Lahdenne2Kari K Eklund3Kristiina Aalto4Department of Rheumatology, Helsinki University Hospital and University of HelsinkiDepartment of Paediatric and Adolescent Medicine, Aarhus University HospitalDepartment of Paediatrics, New Children’s Hospital, Helsinki University Hospital and University of HelsinkiDepartment of Rheumatology, Helsinki University Hospital and University of HelsinkiDepartment of Paediatrics, New Children’s Hospital, Helsinki University Hospital and University of HelsinkiAbstract Background The aim of this long-term follow-up study was to compare the disease characteristics of HLA-B27 positive and negative patients with juvenile idiopathic arthritis (JIA). Methods The study is a cohort study with consecutive cases of newly diagnosed Finnish patients with JIA according to the International League of Associations for Rheumatology (ILAR) criteria [1]. Patients were enrolled between 1997 and 2000 from a defined area of Southern Finland. Clinical data including disease activity and serology were registered during a mean period of 17.5 years. Results 159 patients completed the 18-year follow-up study. HLA-B27 was available for 151 patients, of which 25% were HLA-B27 positive. Chronic uveitis was diagnosed in 30% of HLA-B27 positive and 29% of HLA-B27 negative patients. HLA-B27 positive patients had a lower prevalence of temporomandibular (TMJ) involvement than the antigen negative ones, 19% versus 28%. None of the HLA-B27 positive patients had cervical spine affected compared to 11% of antigen negative patients (p = 0.022). Of the HLA-B27 positive patients, 54% had had biological medication at some point during follow-up versus 25% in the negative group (p = 0.003). At last follow-up, 32% of antigen positive patients were not in remission compared to 18% of the antigen negative (p = 0.017). Conclusions The use of biological medication was more common in HLA-B27 positive patients with JIA. At the 18-year follow-up, more antigen positive patients had active disease compared HLA-B27 negative patients. This real-world follow-up study indicates that the prospects for worse outcome with HLA-B27 positivity in long-term should be taken into consideration.https://doi.org/10.1186/s12969-023-00878-9Juvenile idiopathic arthritisHLA-B27Follow-up studyRemission
spellingShingle Suvi Oili Orvokki Peltoniemi
Mia Glerup
Pekka Lahdenne
Kari K Eklund
Kristiina Aalto
Disease characteristics of HLA-B27 positive and negative finnish patients with juvenile idiopathic arthritis - results of the 18-year cohort follow-up study
Pediatric Rheumatology Online Journal
Juvenile idiopathic arthritis
HLA-B27
Follow-up study
Remission
title Disease characteristics of HLA-B27 positive and negative finnish patients with juvenile idiopathic arthritis - results of the 18-year cohort follow-up study
title_full Disease characteristics of HLA-B27 positive and negative finnish patients with juvenile idiopathic arthritis - results of the 18-year cohort follow-up study
title_fullStr Disease characteristics of HLA-B27 positive and negative finnish patients with juvenile idiopathic arthritis - results of the 18-year cohort follow-up study
title_full_unstemmed Disease characteristics of HLA-B27 positive and negative finnish patients with juvenile idiopathic arthritis - results of the 18-year cohort follow-up study
title_short Disease characteristics of HLA-B27 positive and negative finnish patients with juvenile idiopathic arthritis - results of the 18-year cohort follow-up study
title_sort disease characteristics of hla b27 positive and negative finnish patients with juvenile idiopathic arthritis results of the 18 year cohort follow up study
topic Juvenile idiopathic arthritis
HLA-B27
Follow-up study
Remission
url https://doi.org/10.1186/s12969-023-00878-9
work_keys_str_mv AT suvioiliorvokkipeltoniemi diseasecharacteristicsofhlab27positiveandnegativefinnishpatientswithjuvenileidiopathicarthritisresultsofthe18yearcohortfollowupstudy
AT miaglerup diseasecharacteristicsofhlab27positiveandnegativefinnishpatientswithjuvenileidiopathicarthritisresultsofthe18yearcohortfollowupstudy
AT pekkalahdenne diseasecharacteristicsofhlab27positiveandnegativefinnishpatientswithjuvenileidiopathicarthritisresultsofthe18yearcohortfollowupstudy
AT karikeklund diseasecharacteristicsofhlab27positiveandnegativefinnishpatientswithjuvenileidiopathicarthritisresultsofthe18yearcohortfollowupstudy
AT kristiinaaalto diseasecharacteristicsofhlab27positiveandnegativefinnishpatientswithjuvenileidiopathicarthritisresultsofthe18yearcohortfollowupstudy